IVERIC bio Investor Relations Material
Latest events
Q4 2022
IVERIC bio
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from IVERIC bio Inc
Access all reports
IVERIC bio, Inc. is a biopharmaceutical company specializing in the discovery and development of treatments for retinal diseases. The company's focus includes developing therapies for age-related macular degeneration and other ocular conditions that lead to vision loss. IVERIC bio aims to address unmet medical needs in ophthalmology through innovative research and targeted approaches to eye health. The company is headquartered in Parsippany, New Jersey, and its shares are listed on the NASDAQ.
Latest articles
)
Moncler: From the Mountains to the Runway
The story of Moncler, all the way from its beginnings in the Alps to its journey to some of the most prestigious runways in the world.
16 Apr 2025
)
eToro: Innovation, Growth, and IPO Plans
eToro was founded in 2007 and has grown into a global trading platform with over 40 million users and an extensive offering across several asset classes.
10 Apr 2025
)
Yum! Brands: The Company Behind Pizza Hut, KFC, and Taco Bell
Yum! Brands started at PepsiCo in the 1970s and is home to some of the most well-known brands in the world, such as Pizza Hut, KFC, and Taco Bell.
9 Apr 2025
Ticker symbol
ISEE
Country
🇺🇸 United States